Valeant sees 'unrivaled' growth in possible Allergan merger

Mon Apr 21, 2014 5:36pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 21 (Reuters) - A merger between Valeant Pharmaceuticals International Inc and Allergan Inc would create an "unrivaled platform for growth and value creation" in the healthcare sector, a spokesperson for Valeant said on Monday.

Valeant will finalize and announce terms of its proposal shortly, the spokesperson said. (Reporting by Rod Nickel. Editing by Andre Grenon)